🔎 Trials Near Me

Utama › Glioma › Illinois › Chicago

Kajian klinikal Glioma di Chicago, IL

13 kajian untuk Glioma sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Mengambil pesertaFasa 1/2
  • University of Chicago Comprehensive Cancer Center, Chicago
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003

Targeted Pediatric High-Grade Glioma Therapy

Mengambil pesertaKajian pemerhatian
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Mengambil pesertaFasa 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Mengambil pesertaFasa 3
  • University of Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Mengambil pesertaFasa 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Mengambil pesertaFasa 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 1 hingga 25 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04485559

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Mengambil pesertaFasa 1/2
  • Research Site, Chicago
Umur 18 hingga 130 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT05417594

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Mengambil pesertaFasa 1
  • Northwestern Medicine, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07464925

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Mengambil pesertaFasa 1/2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 1 hingga 26 · Semua jantina · Dikemas kini 10 Jul 2026 · NCT06712875

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Umur 1 hingga 21 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Mengambil pesertaFasa 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 39 Years · Semua jantina · Dikemas kini 29 Mei 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Mengambil pesertaFasa 1/2
  • Northwestern Memorial Hospital, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06810544

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Mengambil pesertaFasa 1
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 18 Years · Semua jantina · Dikemas kini 17 Mac 2026 · NCT04943848

Kajian Glioma di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.